MedTrace Logo

Study on Amino Acid Uptake in Brain Tumors

NCT00204295 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2006-09-14

No results posted yet for this study

Summary

The purpose of this study is to determine the uptake of the amino acid O-(2-\[F-18\]Fluorethyl)-L-tyrosin (FET) in human brain tumors using positron emission tomography. A comparison to MRI and histopathological samples is used.

Conditions

  • Brain Neoplasms

Interventions

DRUG

O-(2-[F-18]Fluorethyl)-L-Tyrosin (FET) - PET

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Matthias Weckesser, MD · Department of Nuclear Medicine, University Hospital Muenster

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00204295 on ClinicalTrials.gov